Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Soolantra

Last reviewed on RxList: 5/7/2018
Soolantra Side Effects Center

Last reviewed on RxList 5/7/2018

Soolantra (ivermectin) cream is a macrocyclic lactone anthelmintic used to treat inflammatory lesions of rosacea. Common side effects of Soolantra include skin burning or stinging sensation and skin irritation where the medicine is applied, dry skin, eye irritation, or red eyes.

Apply a dose of Soolantra to the affected areas of the face once daily. Use a pea-size amount for each area of the face (forehead, chin, nose, each cheek) that is affected. Spread as a thin layer, avoiding the eyes and lips. Soolantra may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Soolantra should only be used if prescribed. This drug passes into breast milk when taken orally. It is unknown if it passes into breast milk when applied topically. Consult your doctor before breastfeeding.

Our Soolantra (ivermectin) cream Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Soolantra Professional Information

SIDE EFFECTS

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

During clinical trials, 2047 subjects with inflammatory lesions of rosacea received SOOLANTRA cream once daily. A total of 1555 subjects were treated once daily for more than 12 weeks, and 519 for approximately one year.

Adverse reactions, reported in ≤1% of subjects treated with SOOLANTRA cream for at least 3 months in vehicle-controlled clinical trials, included skin burning sensation and skinirritation.

Postmarketing Experience

Because adverse reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Local adverse reactions: contact dermatitis and allergic dermatitis. .

Read the entire FDA prescribing information for Soolantra (Ivermectin Cream, 1%)

Related Resources for Soolantra

Related Health

© Soolantra Patient Information is supplied by Cerner Multum, Inc. and Soolantra Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors

CONTINUE SCROLLING FOR RELATED ARTICLE